Furthermore, administration of eNOS inhibitor L-NMMA significantly and partially abolished the beneficial effects of CYP2J3 gene delivery on hypertension and insulin resistance induced by fructose intake, and possible mechanism is associated with increased ET-1, ETA-receptor mRNA expression (data not shown) and reduced sensitivity of insulin to peripheral tissues and organs. The gene discussed is EDN1; the disease is hypertensive disorder.